Atlas Trials

Tolerance Study of Allogeneic of Adipose Tissue Derived Mesenchymal Stroma/Stem Cells (AdMSC) Transplantation in Patients With Critical Limb Ischemia.

Clinical trial NCT06795620 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06795620
Sponsor
University Hospital, Toulouse
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Critical Limb Ischemia
Start date
2025-01-01
Primary completion
2028-01-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.